Piech CT - Search Results

1

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.

Duh MS, Mody SH, McKenzie RS, Lefebvre P, Gosselin A, Bookhart BK, Piech CT. Duh MS, et al. Among authors: piech ct. Drugs Aging. 2006;23(12):969-76. doi: 10.2165/00002512-200623120-00004. Drugs Aging. 2006. PMID: 17154661

2

Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia.

Papatheofanis FJ, McKenzie RS, Mody SH, Suruki RY, Piech CT. Papatheofanis FJ, et al. Among authors: piech ct. Curr Med Res Opin. 2006 May;22(5):837-42. doi: 10.1185/030079906X100113. Curr Med Res Opin. 2006. PMID: 16709305

3

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.

Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS. Lefebvre P, et al. Among authors: piech ct. Curr Med Res Opin. 2006 Sep;22(9):1623-31. doi: 10.1185/030079906X120968. Curr Med Res Opin. 2006. PMID: 16968565

4

Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in anemic predialysis chronic kidney disease patients from an observational study.

Papatheofanis F, Smith C, Mody S, McKenzie RS, Bookhart B, Piech CT. Papatheofanis F, et al. Among authors: piech ct. Am J Ther. 2007 Jul-Aug;14(4):322-7. doi: 10.1097/MJT.0b013e31804bddec. Am J Ther. 2007. PMID: 17667204

5

Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.

Vekeman F, McKenzie RS, Lefebvre P, Watson SH, Mody SH, Piech CT, Duh MS. Vekeman F, et al. Among authors: piech ct. Am J Health Syst Pharm. 2007 Sep 15;64(18):1943-9. doi: 10.2146/ajhp060585. Am J Health Syst Pharm. 2007. PMID: 17823106

6

Anaemia and the risk of injurious falls in a community-dwelling elderly population.

Duh MS, Mody SH, Lefebvre P, Woodman RC, Buteau S, Piech CT. Duh MS, et al. Among authors: piech ct. Drugs Aging. 2008;25(4):325-34. doi: 10.2165/00002512-200825040-00005. Drugs Aging. 2008. PMID: 18361542

7

Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients.

Vekeman F, Yameogo ND, Lefebvre P, Bailey RA, McKenzie RS, Piech CT. Vekeman F, et al. Among authors: piech ct. J Med Econ. 2010;13(4):673-80. doi: 10.3111/13696998.2010.529032. Epub 2010 Nov 4. J Med Econ. 2010. PMID: 21050062 Free article.

8

Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve.

Duh MS, Lefebvre P, Fastenau J, Piech CT, Waltzman RJ. Duh MS, et al. Among authors: piech ct. Oncologist. 2005 Jun-Jul;10(6):438-48. doi: 10.1634/theoncologist.10-6-438. Oncologist. 2005. PMID: 15967837 Free article.

9

The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.

Lefebvre P, Duh MS, Mody SH, Bookhart B, Piech CT. Lefebvre P, et al. Among authors: piech ct. Dis Manag. 2007 Feb;10(1):37-45. doi: 10.1089/dis.2006.626. Dis Manag. 2007. PMID: 17309363

10

Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) : a registry for characterizing anaemia management and outcomes in oncology patients.

Larholt K, Pashos CL, Wang Q, Bookhart B, McKenzie RS, Piech CT. Larholt K, et al. Among authors: piech ct. Clin Drug Investig. 2008;28(3):159-67. doi: 10.2165/00044011-200828030-00003. Clin Drug Investig. 2008. PMID: 18266401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters